Загрузка...
Interim Futility Monitoring Assessing Immune Therapies With a Potentially Delayed Treatment Effect
PURPOSE: Introduction of new immune therapies that may have a delayed beneficial effect necessitates re-evaluation of traditional clinical trial designs in oncology. A key design feature of randomized trials is interim futility monitoring, which allows stopping early if the accruing data convincingl...
Сохранить в:
| Опубликовано в: : | J Clin Oncol |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society of Clinical Oncology
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6366306/ https://ncbi.nlm.nih.gov/pubmed/29949395 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2018.77.7144 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|